AzTrials
AzTrials

ArthroplastyQUASHNCT04480320

Sonography-guided Pericapsular Never Group Block for Hip Arthroplasty

A study testing pericapsular nerve group block in people with Arthroplasty and Nerve Block, run by Guangzhou First People's Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In this study, the investigator will examine the efficacy of Pericapsular nerve group (PENG) block in hip arthroplasty as a post-operative pain management technique, study the analgesia, opioid-sparing effects and motor-blocking effects of the PENG block Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Arthroplasty, Nerve Block, Analgesia
What is being tested?
pericapsular nerve group block
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
71 participants
Where
1 siteChina
Study dates
10 Sep 2020to 31 Mar 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients scheduled for hip arthroplasty

Who cannot join

  • allergy to local anesthetics
  • infection at the injection site
  • patients receiving opioids for chronic analgesic therapy
  • other lower limb neuropathies
  • inability to comprehend visual analog scale (VAS)
  • preexist cognitive dysfunction

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Guangzhou First Municipal People's Hospital

    Guangzhou, Guangdong, 510180

    Xiangcai Ruan, MD, PHD, 8620-81048306, xc_ruan@hotmail.com

    Jun Zheng, MD, Msc, zhengjun19861029@126.com

    Recruiting

Other trials in China

About this study

Official title: Sonography-guided Pericapsular Nerve Group Block for Hip Arthroplasty

In this study, the investigator will examine the efficacy of Pericapsular nerve group (PENG) block in hip arthroplasty as a post-operative pain management technique, study the analgesia, opioid-sparing effects and motor-blocking effects of the PENG block

Read the detailed description

PENG Block group (PG) will receive 0.5%Ropivacaine in 20 ml of saline. Sham Block group (SG) will receive 20 ml of saline Patient will be sedated with IV midazolam before nerve block. After peripheral nerve block ,general anesthesia will be conducted using sufentanyl, propofol and rocuronium for induction and propofol and sevoflurane for maintenance. Tests will be operated after procedure,and recorded up to 48 hours after surgery.

Being tested
pericapsular nerve group block
Keywords
Pericapsular Nerve Group, PENG, hip arthroplasty, Postoperative analgesia, quadriceps strength
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pericapsular nerve group blockProcedure or surgery

    Branches of both the FN and ON provide innervation to the anterior hip capsule. High and low branches of FN provided the majority of innervation to the lateral and superomedial hip capsule. The AON innervates the medial capsule.Both of the nerve close to the periosteum between the iliopubic eminence and AIIS ,by using ultrasound guided technique,these sites can be potential bony landmarks provid approch to the nerve group.

Study groups in NCT04480320
Study groupRoleWhat they receive
Pericapsular nerve group blockExperimentalNot described
Receives: Procedure: pericapsular nerve group block
Saline placebo groupPlacebo comparatorNot described
Receives: Procedure: pericapsular nerve group block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Highest VAS score in recovery room

    Highest VAS score reported in recovery room,patient will be asked questions to measure the highest VAS score experienced in the recovery room before discharge. If the patient had a unexpected long stay at recovery room, the question will be asked at the time point "2 hours after surgery end"

    Measured: before recovery room discharge(up to 2 hours after surgery end)

Secondary outcomes (7)
  1. VAS at rest

    VAS pain score while patient at rest

    Measured: day0 ,day1 ,day2

  2. highest VAS at period

    highest VAS reported at follow up period

    Measured: day0 ,day1 ,day2

  3. quadriceps strength

    Measure quadriceps strength peak value at different time point

    Measured: day0 , day1 ,day2

  4. total opioid consumption

    Measured: up to 2 days after surgery

  5. PONV rate

    postoperative nausea and vomit

    Measured: day0 ,day1 ,day2

  6. Fall incident happened

    Record the fall incident happened,fall is defined as patinent accidently fall to the ground.

    Measured: up to 2 days after surgery

  7. Nerve block range

    A cotton yarn with ethanol will be put on both the surgical and nonsurgical leg to evaluate the cold sensation lost after nerve block.Skin sensation lost will be tested at lateral thigh,medial thigh,front thigh and lateral claf

    Measured: day0 , before discharge from PACU(up to 2 hours after surgery end)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2020
  2. Study start10 Sep 2020
  3. Primary completion31 Mar 2021 (estimated)
  4. Study completion31 Mar 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
71 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04480320
Sponsor's protocol ID
K-2020-085-01
Acronym
QUASH
Status last verified
Sep 2020
First submitted
2 Jul 2020
Last updated
14 Sep 2020
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Zheng J, Pan D, Zheng B, Ruan X. Preoperative pericapsular nerve group (PENG) block for total hip arthroplasty: a randomized, placebo-controlled trial. Reg Anesth Pain Med. 2022 Mar;47(3):155-160. doi: 10.1136/rapm-2021-103228. Epub 2021 Dec 6.

    PubMed 34873023

Questions about this trial

What is this clinical trial studying?

A study testing pericapsular nerve group block in people with Arthroplasty and Nerve Block, run by Guangzhou First People's Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Highest VAS score in recovery room (time frame: before recovery room discharge(up to 2 hours after surgery end)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04480320, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in